Close Menu
    Facebook X (Twitter) Instagram
    Thursday, November 19
    Top Stories:
    • Author Correction: Global Bispecific Antibody Patents and Therapies
    • Ancient Virus May Explain What Makes the Human Brain Unique
    • Single-Cell Analysis Reveals Cas9’s On- and Off-Target Gene Effects
    Facebook X (Twitter) Instagram Pinterest Vimeo
    IO Tribune
    • Home
    • AI
    • Tech
      • Gadgets
      • Fashion Tech
    • Crypto
    • Smart Cities
      • IOT
    • Science
      • Space
      • Quantum
    • OPED
    IO Tribune
    Home » Author Correction: Global Bispecific Antibody Patents and Therapies
    Science

    Author Correction: Global Bispecific Antibody Patents and Therapies

    Lina Johnson MercilliBy Lina Johnson MercilliNovember 18, 2026No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Essential Insights

    Three authors—Chen, Tan, and Zhang—are identified as equal contributors to this work.
    Research spans oncology, breast surgery, dermatology, molecular biology, and cancer precision medicine.
    Institutions across Guangzhou, Shenzhen, Shanwei, Macao, and Stockholm contribute to the collaboration.
    The affiliations connect clinical oncology centers with academic and interdisciplinary research groups.

    A correction, not a new treatment

    An author correction updates the scientific record. The available notice information identifies researchers’ equal contributions and their institutional affiliations. It does not specify what text or data changed. Therefore, it would be misleading to describe a particular correction or claim that it alters the study’s findings.

    Why bispecific antibodies matter

    The article examines patents and medical uses for bispecific antibodies. These engineered medicines can bind to two targets, a feature that may help researchers direct treatment more precisely. However, a patent landscape maps inventions; it does not prove that a therapy is safe, effective or available to patients.

    Promise, with practical limits

    For patients, more targeted treatments could eventually offer new options and improve quality of life. Yet development takes time. Researchers must test benefits, risks and access, while patent rights can shape who develops a medicine and when it reaches the public. Corrections also matter: Clear records help readers assess research and follow progress responsibly.

    Stay Ahead with the Latest Tech Trends

    Learn how the Internet of Things (IoT) is transforming everyday life.

    Access comprehensive resources on space and science by visiting NASA.

    Sci-BioV1

    Asia Biotech health Innovation Medical medicine Tech VT1
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleNvidia’s First Post-Jensen All-Hands: Raises and More Equity
    Next Article Can Nvidia Deliver? Colette Kress Says Yes
    Avatar photo
    Lina Johnson Mercilli
    • Website

    Lina Johnson Marcelli is the editor for IO Tribune, bringing over two decades of experience in journalism to her role. With a BA in Journalism, she is passionate about delivering impactful stories that resonate with readers. Known for her keen editorial vision and leadership, Lina is dedicated to fostering innovative storytelling across the publication. Outside of work, she enjoys exploring new media trends and mentoring aspiring journalists.

    Related Posts

    Fashion Tech

    Kate Middleton’s India 2026 Tour Outfits: Every Look

    November 19, 2026
    Gadgets

    YouTube Music Web Rolls Out to More Users

    November 19, 2026
    AI

    Can Nvidia Deliver? Colette Kress Says Yes

    November 18, 2026
    Add A Comment

    Comments are closed.

    Must Read

    Kate Middleton’s India 2026 Tour Outfits: Every Look

    November 19, 2026

    YouTube Music Web Rolls Out to More Users

    November 19, 2026

    Can Nvidia Deliver? Colette Kress Says Yes

    November 18, 2026

    Author Correction: Global Bispecific Antibody Patents and Therapies

    November 18, 2026

    Nvidia’s First Post-Jensen All-Hands: Raises and More Equity

    November 18, 2026
    Categories
    • AI
    • Crypto
    • Fashion Tech
    • Gadgets
    • IOT
    • OPED
    • Quantum
    • Science
    • Smart Cities
    • Space
    • Tech
    Most Popular

    YouTube’s Premium Lite: Now with Background Play & Downloads!

    February 25, 2026

    Why Data Scientists Can’t Ignore Quantum Computing

    March 30, 2026

    Is This the XLM Breakout Bulls Have Craved?

    August 14, 2025
    Our Picks

    Apple Maps Set to Navigate You to Ads

    March 24, 2026

    Unlocking the Universe: Antarctic Ice as a Cosmic Detective

    May 26, 2026

    Why YouTube’s Auto-Dubbing Needs an Off Switch

    May 5, 2026
    Categories
    • AI
    • Crypto
    • Fashion Tech
    • Gadgets
    • IOT
    • OPED
    • Quantum
    • Science
    • Smart Cities
    • Space
    • Tech
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About Us
    • Contact us
    Copyright © 2025 Iotribune.comAll Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.